Current Trends in Arbovirus Outbreaks and Research

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".

Deadline for manuscript submissions: 31 December 2026 | Viewed by 187

Special Issue Editor

Special Issue Information

Dear Colleagues,

Arboviruses continue to represent an urgent and expanding global health challenge. In recent years, we have witnessed unprecedented outbreaks, geographic expansions, and shifts in transmission dynamics involving a wide range of arboviral pathogens. These changes are driven by a convergence of viral evolution, climate variability, anthropogenic environmental change, and increasing global connectivity.

After 20 years, chikungunya virus (CHIKV) has re-emerged in Réunion Island (2024–2025), causing a major outbreak associated with a viral clade harboring mutations such as E1-A226V, known to enhance transmission via Aedes albopictus. Similar mutations were responsible for the large-scale outbreaks that began in the Indian Ocean in 2005 and were followed by autochthonous transmission events in Europe.

This adaptation may also be contributing to the current chikungunya outbreaks in Europe and China. In 2025, Europe is experiencing both the earliest seasonal onset and the widest geographic spread of local chikungunya transmission ever recorded, while China is undergoing its largest epidemic to date. Notably, the European summer of 2025 has broken historical temperature records, creating increasingly favorable conditions for arboviral transmission in temperate regions via Aedes albopictus, a vector with expanding distribution.

These developments underscore the growing global risk of sustained arbovirus transmission beyond the tropics and raise concerns about future outbreaks in previously unaffected areas across Europe, Asia, and North America.

At the same time, the Americas are experiencing the largest arbovirus epidemics ever recorded, with explosive outbreaks of dengue, chikungunya, and yellow fever in several Latin American countries. These crises are straining surveillance systems and health services, exposing gaps in early detection, clinical management, and public health response.

Compounding this complex scenario is the rapid and unprecedented geographic expansion of Oropouche virus (OROV), a peribunyavirus historically restricted to the Amazon basin. In recent years, OROV has been detected in urban areas across Brazil, including bordering regions and signaling potential spread into the Caribbean. Despite its epidemic potential, OROV remains under-recognized and frequently misdiagnosed, presenting a silent but growing public health threat.

Topics of Interest

We invite submissions in the form of original research articles, reviews, short communications, case reports, viewpoints, and modeling studies related to the following topics:

  • Arbovirus surveillance systems and outbreak investigations;
  • Molecular epidemiology, viral evolution, and genomic signatures of adaptation;
  • Vector competence, adaptation, and ecology in urban and temperate settings;
  • Climate change and environmental drivers of arboviral transmission;
  • Spillover risk and zoonotic interfaces;
  • Emerging and neglected arboviruses (e.g., Oropouche, Mayaro): detection, expansion, and under-recognition;
  • Diagnostic innovations and challenges in differential diagnosis;
  • Arbovirus-related complications and mortality (neurological, congenital, chronic);
  • Immunopathogenesis and host response to infection;
  • Vaccine and antiviral development, and evaluation of public health applications;
  • Health system preparedness, clinical management, and risk communication;
  • Comparative studies across geographic regions, arbovirus species, or outbreak contexts.

Prof. Dr. André Ricardo Ribas Freitas
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • arboviral infections
  • Dengue
  • Chikungunya
  • Zika
  • Oropouche
  • West Nile
  • Usutu
  • Tick borne encephalitis
  • Toscana
  • Sandfly Fever Sicilian
  • Flaviviridae
  • Bunyavirales
  • Togaviridae
  • viral evolution
  • vector ecology
  • climate change
  • emerging arboviruses
  • surveillance
  • public health preparedness

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 2945 KB  
Article
Differential Profile of Hemostasis in Dengue Fever Before and After COVID-19
by Alanna Calheiros Santos, Julya Farias Carneiro, Anna Paula de Souza e Silva Sales, Mariana Gandini, Flávia Barreto dos Santos, Paulo Vieira Damasco, Luis José de Souza, Elzinandes Leal de Azeredo and Luzia Maria de-Oliveira-Pinto
Viruses 2025, 17(11), 1431; https://doi.org/10.3390/v17111431 - 28 Oct 2025
Abstract
Dengue and COVID-19 are viral diseases characterized by coagulopathies, with Dengue associated with fibrinolysis and COVID-19 with prothrombotic events. Furthermore, cross-reactivity between anti-SARS-CoV-2 and anti-DENV antibodies may confer protective immunity or exacerbate disease severity. Our investigation explored the impact of prior COVID-19 exposure [...] Read more.
Dengue and COVID-19 are viral diseases characterized by coagulopathies, with Dengue associated with fibrinolysis and COVID-19 with prothrombotic events. Furthermore, cross-reactivity between anti-SARS-CoV-2 and anti-DENV antibodies may confer protective immunity or exacerbate disease severity. Our investigation explored the impact of prior COVID-19 exposure on the immunopathogenesis of Dengue, focusing on hemostatic parameters. We quantified nitrites, procoagulant, anticoagulant, and fibrinolytic mediators in the plasma of Dengue patients before and after the COVID-19 pandemic. We also evaluated the influence of plasma from dengue patients on platelet activation in vitro using platelets from healthy donors exposed to DENV-2. Hemorrhagic manifestations were more frequent in pre-COVID-19 Dengue, while nitrite levels were elevated in post-COVID-19 Dengue patients, particularly among those without hemorrhagic signs. Among procoagulant factors, tissue factor (TF) levels were increased in post-COVID-19 Dengue, whereas Factor XIII was higher in pre-COVID-19 Dengue. In contrast, antithrombin (an anticoagulant) and plasminogen (a profibrinolytic factor) were more elevated in pre-COVID-19 Dengue than in post-COVID-19 cases. In vitro, DENV-2-infected platelets exposed to plasma of Dengue patients before and after COVID-19 showed decreased nitrite production in relation to DENV-2 alone. These findings suggest that prior COVID-19 exposure may influence hemostatic responses in Dengue, potentially modulating disease pathophysiology and opening new avenues for research and therapeutic strategies. Full article
(This article belongs to the Special Issue Current Trends in Arbovirus Outbreaks and Research)
Show Figures

Figure 1

Back to TopTop